Browsing Tag

Moderna

The pharmaceutical company Moderna announced that it began the last phase of clinical trials for the development of four new vaccines against latent infections, including chickenpox and herpes, as well as the norovirus responsible for gastroenteritis outbreaks. The four vaccines against latent…
Read More...

Moderna earns $12 billion from its Spikevax vaccine

The American laboratory Moderna closed 2021 with a net profit of 12,202 million dollars (10,982 million euros) compared to the losses of 747 million (672 million euros) that it recorded in the previous year, thanks to the millions of doses…